# 바이오스페이스 일일 뉴스 리포트 - 2025년 05월 30일


## 주요 헤드라인

1. **Analysts Brush Off Intellia’s Adverse Event but Gene Therapy Safety Concerns Continue (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/analysts-brush-off-intellias-adverse-event-but-gene-therapy-safety-concerns-continue>

2. **Analysts Brush Off Intellia’s Adverse Event but Gene Therapy Safety Concerns Continue (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/analysts-brush-off-intellias-adverse-event-but-gene-therapy-safety-concerns-continue>

3. **Merck, Daiichi Sankyo Pull Lung Cancer Filing for ADC, Citing Underwhelming Survival Findings (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/merck-daiichi-sankyo-pull-nsclc-filing-for-adc-citing-underwhelming-survival-findings>

4. **iTeos To Close Down After TIGIT Fail (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/iteos-to-close-down-after-tigit-fail>

5. **Novo Opposes Pharma Tariffs, Urges Crackdown on Illicit Chinese Semaglutide (#뉴스)**
   - Article content not available
   <https://www.biospace.com/policy/novo-opposes-pharma-tariffs-urges-crackdown-on-illicit-chinese-semaglutide>

6. **Opinion (#뉴스)**
   - Article content not available
   <https://www.biospace.com/policy/opinion-drug-price-transparency-in-us-is-easier-said-than-done>

7. **Opinion (#뉴스)**
   - Article content not available
   <https://www.biospace.com/policy/opinion-drug-price-transparency-in-us-is-easier-said-than-done>


---
*2025년 05월 30일 바이오스페이스 뉴스 피드에서 생성된 리포트*